Chief Medical Officer
Jula Inrig, M.D. is the Chief Medical Officer at Travere Therapeutics, Inc. (NASDAQ: TVTX), a position she has held since joining the company in January 2022.[[1]](https://travere.com/our-company/leadership-and-board/jula-inrig-m-d/)[[2]](https://ir.travere.com/press-releases/news-details/2022/Travere-Therapeutics-Appoints-Jula-Inrig-M-D--as-Chief-Medical-Officer-01-04-2022/default.aspx) In this role, she oversees medical functions, clinical development, clinical operations, and drug safety/pharmacovigilance, bringing over 15 years of expertise in medical oversight, drug development, clinical trial planning, execution, and global regulatory engagement.[[1]](https://travere.com/our-company/leadership-and-board/jula-inrig-m-d/)[[2]](https://ir.travere.com/press-releases/news-details/2022/Travere-Therapeutics-Appoints-Jula-Inrig-M-D--as-Chief-Medical-Officer-01-04-2022/default.aspx) Prior to Travere, Dr. Inrig served as Global Head of the Renal Center of Excellence at IQVIA, where she led the design, execution, and strategy of clinical trials resulting in FDA and EMA approvals for treatments in autosomal dominant polycystic kidney disease (ADPKD) and diabetic kidney disease, and managed over 45 trials across 50 countries enrolling more than 25,000 patients, including pivotal phase 3 trials in FSGS, IgAN, and lupus nephritis.[[1]](https://travere.com/our-company/leadership-and-board/jula-inrig-m-d/)[[2]](https://ir.travere.com/press-releases/news-details/2022/Travere-Therapeutics-Appoints-Jula-Inrig-M-D--as-Chief-Medical-Officer-01-04-2022/default.aspx)
Dr. Inrig is board-certified in nephrology and internal medicine, with over 20 years of experience in the medical field.[[3]](https://www.healthgrades.com/physician/dr-jula-inrig-23g2v)[[5]](https://www.doximity.com/pub/jula-inrig-md) She has served on the board of the Kidney Health Initiative, a public-private partnership with the FDA, and in advisory roles for the American Society of Nephrology, National Kidney Foundation, and American Heart Association.[[1]](https://travere.com/our-company/leadership-and-board/jula-inrig-m-d/)[[2]](https://ir.travere.com/press-releases/news-details/2022/Travere-Therapeutics-Appoints-Jula-Inrig-M-D--as-Chief-Medical-Officer-01-04-2022/default.aspx) Recognized as one of PharmaVOICE’s '100 Most Inspiring People' in life sciences, a 'Top 50 Women Leader of Los Angeles' by Women We Admire, and a Luminary by the Healthcare Businesswomen’s Association, she holds faculty positions at the University of California, Irvine, and as an adjunct at Duke University School of Medicine.[[1]](https://travere.com/our-company/leadership-and-board/jula-inrig-m-d/) Dr. Inrig earned her M.D. from Loma Linda University, completed her internal medicine residency and nephrology fellowship, and obtained a Master of Health Science at Duke University, along with a B.A. from California State University, Sacramento.[[1]](https://travere.com/our-company/leadership-and-board/jula-inrig-m-d/)[[2]](https://ir.travere.com/press-releases/news-details/2022/Travere-Therapeutics-Appoints-Jula-Inrig-M-D--as-Chief-Medical-Officer-01-04-2022/default.aspx)[[3]](https://www.healthgrades.com/physician/dr-jula-inrig-23g2v)
View full insider profile →
